PressAugust 31, 2023 MAPS Launches Online Video Sessions from Psychedelic Science 2023 with The Virtual Trip
BlogAugust 30, 2023 Controversial Departure: Decriminalize Nature President Steps Down Amidst Strong Reactions
PressAugust 29, 2023 PSYC Enters Strategic Partnership with Target Media to Help Accelerate Audience and Revenue Growth Opportunities
PressAugust 29, 2023 Silo Wellness Announces LOI to Acquire NUGL/Kaya in a Transaction Valued at CAD $43,289,624.60; CSE to Halt Trading Until Shareholder Approval
PressAugust 28, 2023 Red Light Holland Psilocybin Microdosing Capsules Aimed To Be Distributed by Nubu Pharmaceuticals In Australia Pass 8 Weeks of Stability Testing By CCREST Laboratories
PressAugust 25, 2023 Canadian Survey Shows People Aren’t Talking to Doctors About Medical Use of Psychedelics
PressAugust 25, 2023 Sunstone Therapies in Collaboration with the University of Vermont Announces Publication of Study Showing Feasibility of Direct Observation of Therapeutic Connection in Psilocybin-Assisted Therapy
PressAugust 24, 2023 Incannex to Prepare FDA IND Application for Psilocybin-assisted Psychedelic Psychotherapy Program, Known as Psi-GAD
PressAugust 24, 2023 Core One Labs : Commends Study Exploring Psychedelics’ Efficacy in Providing Relief for Chronic Pain Conditions
PressAugust 24, 2023 MindBio Therapeutics Corp. Begins Dosing Mb22001 in Phase 2 Clinical Trial in World’s First Take-Home Microdosing Study in Patients with Depression
PressAugust 24, 2023 Diamond Equity Research Initiates Coverage on Enveric Biosciences Inc. (NASDAQ: ENVB)
PressAugust 23, 2023 GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates
PressAugust 22, 2023 Revive Therapeutics Announces Initiation of Novel Bucillamine Formulation Development
PressAugust 21, 2023 Psyence Group Announces Closing of Private Placement & Conclusion of Loan Agreement
